4WEB Medical Receives 510(k) Clearance to Market Their Lumbar Plating Solution

What To Know

  • 4WEB Medical expects to launch its hyperlordotic lateral implant line and an Anterior-to-Psoas implant by the end of the year making the 4WEB Total Lateral Solution one of the most comprehensive offerings in the lateral spine space.
  • The latest addition to the 4WEB portfolio further demonstrates the company’s commitment to developing a comprehensive lateral spine program.

4WEB Medical notes the new plating solution consists of a wide variety of modular plating configurations to address multiple lumbar spine pathologies and approaches.

The device provides an integrated and non-integrated offering with a one, two, and four screw option. The plate design also features a single-step locking mechanism to prevent screw backout.

“Our continued commitment to new product development led to revenue growth in FY 2020 driven by the launch of the Stand Alone Cervical and ALIF product lines,”  said Jim Bruty, Sr. Vice President of Sales and Marketing at 4Web Medical. “The Lumbar Plating Solution will contribute significantly to 2021 top-line growth by enabling surgeon customers to utilize the company’s Truss Implant Technology in more advanced lateral procedures such as anterior longitudinal ligament release techniques.”

The latest addition to the 4WEB portfolio further demonstrates the company’s commitment to developing a comprehensive lateral spine program. 4Web Medical currently has procedural-based solutions developed for Direct Lateral, Anterior-to-Psoas (ATP),  and Prone Lateral approaches to the lumbar spine. The company also has dedicated resources for the future development of a novel lateral deformity solution.

4WEB Medical expects to launch its hyperlordotic lateral implant line and an Anterior-to-Psoas implant by the end of the year making the 4WEB Total Lateral Solution one of the most comprehensive offerings in the lateral spine space.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

OTHER NEWS

XT-Thrive® Drug Master File (DMF) Accepted by the FDA | Reports X-Therma

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte™ Image Guided Crossing and Re-Entry Catheter System

Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System. The company looks forward to bringing this revolutionary technology to clinicians, and patients in need.

Transforming Tricuspid Valve Care: FDA Gives Green Light to Abbott’s TriClip™

"The U.S. approval of TriClip is a significant advancement for people suffering from tricuspid regurgitation, a heart condition that negatively impacts their quality of life and puts them at grave risk of serious health issues," said Paul Sorajja, M.D., the Roger L. and Lynn C. Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation and director of the Center for Valve and Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital and co-principal investigator of the TRILUMINATE™ Pivotal trial. "With TriClip, physicians can offer patients a therapy option backed by excellent safety and effectiveness to help restore tricuspid native valve performance without subjecting them to high-risk open-heart surgery that may not be feasible for individuals with TR who are generally older and sicker."

HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device

This make it one of the only wearable OTC anti-migraine device that is available without a prescription in the U.S.

By using this website you agree to accept Medical Device News Magazine Privacy Policy